GRAIL Submits FDA Premarket Approval Application for the Galleri® Multi-Cancer Early Detection Test
FDA Submission Marks a Pivotal Milestone in Advancing Early Cancer Detection, Addressing Unmet Needs in Cancer Screening
Meta Platforms Cuts Metaverse Spending, Focuses on AI
Robert Half Releases Q1 2026 Earnings Guidance
Business
Rothschild & Co Redburn Upgrades Meta Platforms (NASDAQ:META) to Buy
Analysts raise price target on social media giant's stock to $900 from $740

Meta Posts Stronger-Than-Expected Q4 Results Despite Rising Costs
Advertising revenue surge drives earnings beat, but expenses continue to climb for tech giant.
PacBio to Report Q4 and Full Year 2025 Results on February 12
The genomics company will host a conference call to discuss its latest financial performance.